Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling
The FASEB Journal · 2024
DOI: 10.1096/fj.202400211rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Zhijun Geng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Colitis, ErbB Receptors. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), First Affiliated Hospital of Bengbu Medical University Science Fund for Distinguished Young Scholars, Anhui Province University Outstanding Youth Research Project.
Abstract (Originalsprache)
Excessive apoptosis of intestinal epithelial cells leads to intestinal barrier dysfunction, which is not only one of the pathological features of inflammatory bowel disease (IBD) but also a therapeutic target. A natural plant extract, Ginkgetin (GK), has been reported to have anti‐apoptotic activity, but its role in IBD is unknown. This study aimed to explore whether GK has anti‐colitis effects and related mechanisms. An experimental colitis model induced by dextran sulfate sodium (DSS) was established, and GK was found to relieve colitis in DSS‐induced mice as evidenced by improvements in weight loss, colon shortening, Disease Activity Index (DAI), macroscopic and tissue scores, and proinflammatory mediators. In addition, in DSS mice and TNF‐α‐induced colonic organoids, GK protected the intestinal barrier and inhibited intestinal epithelial cell apoptosis, by improving permeability and inhibiting the number of apoptotic cells and the expression of key apoptotic regulators (cleaved caspase 3, Bax and Bcl‐2). The underlying mechanism of GK's protective effect was explored by bioinformatics, rescue experiments and molecular docking, and it was found that GK might directly target and activate EGFR, thereby interfering with PI3K/AKT signaling to inhibit apoptosis of intestinal epithelial cells in vivo and in vitro. In conclusion, GK inhibited intestinal epithelial apoptosis in mice with experimental colitis, at least in part, by activating EGFR and interfering with PI3K/AKT activation, explaining the underlying mechanism for ameliorating colitis, which may provide new options for the treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Central Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
- Anhui Province Key Laboratory of Basic and Translational Research of Inflammation-related Diseases, Bengbu, Anhui, China.
- Department of Gastrointestinal Surgery, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
- Department of Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
- School of Clinical Medicine, Bengbu Medical University, Bengbu, Anhui, China.
ORCID-Profile: Zhijun Geng, Lugen Zuo, Jing Li, Lixia Yin, Jingjing Yang, Ting Duan, Lian Wang, Xiaofeng Zhang, Xue Song, Yueyue Wang, Jianguo Hu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- First Affiliated Hospital of Bengbu Medical University Science Fund for Distinguished Young Scholars
- Anhui Province University Outstanding Youth Research Project
- National Natural Science Foundation of China
Zitieren
APA
Geng, Z., Zuo, L., Li, J., Yin, L., Yang, J., Duan, T., Wang, L., Zhang, X., Song, X., Wang, Y., & Hu, J. (2024). Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling. The FASEB Journal. https://doi.org/10.1096/fj.202400211rr
Vancouver
Geng Z, Zuo L, Li J, Yin L, Yang J, Duan T, et al. Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling. The FASEB Journal. 2024. doi:10.1096/fj.202400211rr
BibTeX
@article{Geng2024,
author = {Geng, Zhijun and Zuo, Lugen and Li, Jing and Yin, Lixia and Yang, Jingjing and Duan, Ting and Wang, Lian and Zhang, Xiaofeng and Song, Xue and Wang, Yueyue and Hu, Jianguo},
title = {Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400211rr}
}
EUVIMED